AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20533760
Drug: Commercial pastilles
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial pastilles (8 mg), n = 123
Trial: 21991892
Drug: Bronchodilator administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bronchodilator administration
Trial: 12568852
Drug: Recombinant IL‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Recombinant IL‐1 receptor antagonist
Trial: 12568852
Drug: Anti‐IL‐1beta antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti‐IL‐1beta antibody
Trial: 10867375
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with specific allergens (subcutaneous administration of the vaccine)
Trial: 8623949
Drug: Large-dose fentanyl
RxNorm normalized name: fentanyl Metered Dose Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large-dose fentanyl anesthesia (LDFA)
Trial: 8623949
Drug: Small-dose fentanyl
RxNorm normalized name: fentanyl Metered Dose Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small-dose fentanyl anesthesia (SDFA)
Trial: 1423201
Drug: Cumulative dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cumulative dose of cyclophosphamide < 7.5 g/m2
Trial: 1423201
Drug: Cumulative dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cumulative dose of cyclophosphamide > 7.5 g/m2
Trial: 3804185
Drug: Omeprazole 5
RxNorm normalized name: esomeprazole 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 5 mg daily
Trial: 21753734
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no special treatments for the extraction socket)
Trial: 9684190
Drug: Sublingual birch
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual birch pollen extract
Trial: 7979841
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg fluvastatin sodium once daily
Trial: 7979841
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg fluvastatin sodium twice daily
Trial: 29054679
Drug: Conventional method
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional method using a custom tray border moulded with impression compound and silicone
Trial: 27261067
Drug: Quadrivalent meningococcal
RxNorm normalized name: MENINGOCOCCAL B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent meningococcal vaccine
Trial: 20461767
Drug: Fibrin glue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin glue spray applied to the axillary fossa plus placement of closed suction drainage
Trial: 18991123
Drug: Citalopram treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citalopram treatment with remission of maternal depression
Trial: 9485226
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (NO) at 20 ppm (n = 6)
Trial: 21798883
Drug: Sifalimumab (0.3,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sifalimumab (0.3, 1, 3, 10 or 30 mg/kg)
Trial: 25179088
Drug: Mouthwash solution
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mouthwash solution containing lysine (0.4%) and glycerol monolaurate (0.2%) (LGM)
Trial: 25179088
Drug: Traditional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional treatment for gastric eradication
Trial: 25179088
Drug: Traditional drug
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional drug gastric eradication and teeth cleaning (TC)
Trial: 25179088
Drug: Treatment of
RxNorm normalized name: DRUGS FOR TREATMENT OF LEPRA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment of oral infection
Trial: 8607501
Drug: Ciprofloxacin 500
RxNorm normalized name: ciprofloxacin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin 500 mg twice daily plus metronidazole 250 mg four times daily
Trial: 8607501
Drug: Methylprednisolone 0.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 0.7 mg/kg/day with variable tapering to 40 mg
Trial: 6129858
Drug: Clobazam (Frisium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobazam (Frisium 20) administered in the morning for 28 days
Trial: 6129858
Drug: Clobazam (Frisium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clobazam (Frisium 20) administered at night for 28 days
Trial: 27071768
Drug: Pramlintide 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pramlintide 30 or 60 µg
Trial: 24501005
Drug: LDV 90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDV 90 mg QD for 24 weeks
Trial: 24501005
Drug: LDV 90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDV 90 mg QD for 12 weeks
Trial: 24501005
Drug: LDV 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDV 30 mg QD for 24 weeks
Trial: 24501005
Drug: LDV 90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDV 90 mg QD for 12 weeks in patients with vRVR
Trial: 24501005
Drug: LDV 90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LDV 90 mg QD for 24 weeks in patients with vRVR
Trial: 21822978
Drug: Heparin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin plus octreotide combination treatment post-TACE
Trial: 21822978
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no heparin plus octreotide treatment)
Trial: 17150024
Drug: Natalizumab monotherapy
RxNorm normalized name: Natalizumab
DrugBank: Natalizumab (DB00108)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Natalizumab monotherapy 300 mg intravenous every 4 weeks
Trial: 9663954
Drug: Long muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long muscle length (bout L)
Trial: 3276280
Drug: Tranylcypromine (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tranylcypromine (average dose, 40 mg/d)
Trial: 3276280
Drug: Carbamazepine (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbamazepine (average dose, 820 mg/d)
Trial: 3276280
Drug: Trifluoperazine (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trifluoperazine (average dose, 7.8 mg/d)
Trial: 3276280
Drug: Alprazolam (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (average dose, 4.7 mg/d)
Trial: 1827023
Drug: Intravenous isradipine
RxNorm normalized name: Isradipine
DrugBank: Isradipine (DB00270)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous isradipine (0.5 mg, n = 10)
Trial: 793779
Drug: Bumetanide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bumetanide (1 mg to 3 mg daily)
Trial: 793779
Drug: Frusemide (equipotent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide (equipotent doses)
Trial: 28392215
Drug: Advanced oral
RxNorm normalized name: Imodium Advanced Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advanced oral hygiene care programme (AOHCP) comprising a powered toothbrush, 0.2% chlorhexidine mouthrinse, toothpaste, and oral hygiene instruction
Trial: 28392215
Drug: Conventional oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional oral hygiene care programme (COHCP) comprising a manual toothbrush, toothpaste, and oral hygiene instruction
Trial: 16287365
Drug: Runners Advantage
RxNorm normalized name: Advantage Multi
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Runners Advantage (RA) creatine serum (5 ml containing 2.5 g of Cr)
Trial: 9322568
Drug: Beta-carotene (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (90 mg/d for 3 weeks)
Trial: 9322568
Drug: Beta-carotene (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (50 mg every other day for 10-12 years)
Trial: 19917951
Drug: Daily text-message
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily text-message reminders for 6 weeks
Trial: 15055205
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil 10 mg/day orally
Trial: 15055205
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil 10 mg/day
Trial: 1799473
Drug: Interferon alfa‐2b
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa‐2b maintenance therapy
Trial: 25548141
Drug: Candesartan (+diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Candesartan (+diuretics as needed)
Trial: 10431100
Drug: Sublingual-swallow immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual-swallow immunotherapy (SLIT) with pre-coseasonal treatment
Trial: 10431100
Drug: Sublingual-swallow immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual-swallow immunotherapy (SLIT) with preseasonal treatment
Trial: 10431100
Drug: Sublingual-swallow immunotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual-swallow immunotherapy (SLIT) with coseasonal treatment (highest maintenance dose)
Trial: 2128047
Drug: Combined oral
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined oral contraceptive pill (placebo week)
Trial: 375793
Drug: Physiologic (0.9%)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physiologic (0.9%) saline solution
Trial: 21414216
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care treatment for depression, smoking, and physical activity promotion
Trial: 19568921
Drug: Omega-3 fatty
RxNorm normalized name: Omega-3 fatty acid
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omega-3 fatty acids supplemented parenteral nutrition (0.8 g/kg/day soybean oil + 0.2 g/kg/day omega-3 FAs)
Trial: 19568921
Drug: Standard soybean-oil
RxNorm normalized name: Soybean Oil
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard soybean-oil based fat (1.0 g/kg/day omega-6 FAs)
Trial: 17760535
Drug: Early-loaded dental
RxNorm normalized name: benzyl alcohol
DrugBank: Benzyl alcohol (DB06770)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Early-loaded dental implants (N = 18)
Trial: 17760535
Drug: Delayed-loaded dental
RxNorm normalized name: Dental Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed-loaded dental implants (N = 16)
Trial: 6107116
Drug: Lorazepam 1
RxNorm normalized name: lorazepam 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lorazepam 1 mg three times daily
Trial: 6107116
Drug: Placebo 1
RxNorm normalized name: placebo 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo 1 capsule three times daily
Trial: 20606118
Drug: Aggressive decongestion
RxNorm normalized name: Qlearquil Nasal Decongestant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aggressive decongestion (higher doses of loop diuretics, greater fluid loss)
Trial: 18284263
Drug: Probiotics (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (various strains including Lactobacillus rhamnosus GG) administered for 1 or 2 months
Trial: 18284263
Drug: Probiotics (Lactobacillus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probiotics (Lactobacillus rhamnosus GG) administered perinatally to mothers and to infants for the first 6 months
Trial: 18284263
Drug: L. acidophilus
RxNorm normalized name: L. acidophilus/L.bulgaricus ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L. acidophilus administered for the first 6 months of life
Trial: 14738128
Drug: Application of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Application of a 2% sodium fluoride gel and exposure to the oral cavity (F)
Trial: 14738128
Drug: Exposure to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exposure to the oral cavity (C+)
Trial: 8984570
Drug: rubber‐band ligature,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rubber‐band ligature, anal dilator and Kamillosan ointment
Trial: 1773325
Drug: Epidural analgesia
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural analgesia with continuous infusion of epidural fentanyl
Trial: 25481454
Drug: Healthy School
RxNorm normalized name: Healthy Mama
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Healthy School and Drugs (HSD) program
Trial: 22916320
Drug: Korean Red
RxNorm normalized name: Korean ginseng root
DrugBank: Ginseng (DB01404)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Korean Red Ginseng (KRG) 4.5 g/d for 12 weeks
Trial: 24906384
Drug: 131I therapy
RxNorm normalized name: tetracycline
DrugBank: Tetracycline (DB00759)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 131I therapy
Trial: 28570723
Drug: Oral X-82
RxNorm normalized name: Gas-X Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral X-82 (50 mg alternate days)
Trial: 28570723
Drug: Oral X-82
RxNorm normalized name: Gas-X Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral X-82 (50 mg daily)
Trial: 28570723
Drug: Oral X-82
RxNorm normalized name: Gas-X Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral X-82 (100 mg alternate days)
Trial: 28570723
Drug: Oral X-82
RxNorm normalized name: Gas-X Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral X-82 (100 mg daily)
Trial: 28570723
Drug: Oral X-82
RxNorm normalized name: Gas-X Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral X-82 (200 mg daily)
Trial: 28570723
Drug: Oral X-82
RxNorm normalized name: Gas-X Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral X-82 (300 mg daily)
Trial: 28570723
Drug: Oral X-82
RxNorm normalized name: Gas-X Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral X-82 (all doses)
Trial: 25065017
Drug: Family-aided Assertive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Family-aided Assertive Community Treatment (FACT)
Trial: 23278647
Drug: Surinabant 20
RxNorm normalized name: Surinabant
DrugBank: Surinabant (DB13070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surinabant 20 mg
Trial: 23278647
Drug: Surinabant 60
RxNorm normalized name: Surinabant
DrugBank: Surinabant (DB13070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surinabant 60 mg
Trial: 23278647
Drug: Surinabant 5
RxNorm normalized name: Surinabant
DrugBank: Surinabant (DB13070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surinabant 5 mg
Trial: 9349067
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg with droperidol 0.75 mg
Trial: 9349067
Drug: Ondansetron 8
RxNorm normalized name: ondansetron 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ondansetron 8 mg with droperidol 1.25 mg
Trial: 8455964
Drug: Outpatient group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Outpatient group cognitive therapy
Trial: 8455964
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy in combination with relaxation training
Trial: 8455964
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment conditions (including WL)
Trial: 3816293
Drug: Mequitazine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mequitazine (5 mg twice daily for 14 days)
Trial: 17367953
Drug: Manual-guided group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual-guided group behavioral therapies (Cognitive Behavioral Therapy or Twelve Step Facilitation)
Trial: 12003439
Drug: Elk velvet
RxNorm normalized name: velvet grass pollen extract
DrugBank: Holcus lanatus pollen (DB10395)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elk velvet antler (2 capsules, 215 mg each)
Trial: 12003439
Drug: Elk velvet
RxNorm normalized name: velvet grass pollen extract
DrugBank: Holcus lanatus pollen (DB10395)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elk velvet antler (4 capsules, 215 mg each)
Trial: 12003439
Drug: Elk velvet
RxNorm normalized name: velvet grass pollen extract
DrugBank: Holcus lanatus pollen (DB10395)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elk velvet antler (6 capsules, 215 mg each)
Trial: 7614523
Drug: Nabumetone, 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nabumetone, 1,000 mg once daily
Trial: 2203262
Drug: Naproxen 500
RxNorm normalized name: naproxen 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naproxen 500 mg in the morning and 250 mg in the evening
Trial: 3914703
Drug: Sulindac 200
RxNorm normalized name: sulindac 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulindac 200 mg twice a day
Trial: 29231431
Drug: Montelukast sodium
RxNorm normalized name: Montelukast Sodium
DrugBank: Montelukast (DB00471)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Montelukast sodium (5 mg once daily for 3 months)
Trial: 25169119
Drug: Neoadjuvant chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemoradiotherapy (CRT) - cisplatin and 5-fluorouracil with 45 Gy of concurrent radiotherapy
Trial: 25169119
Drug: Perioperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative chemotherapy (PCT) - docetaxel, cisplatin, 5-FU
Trial: 25169119
Drug: Perioperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perioperative chemotherapy (PCT)
Trial: 21493739
Drug: Warfarin (low-intensity
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin (low-intensity monitored-dose, target INR 1.5 to 1.9)
Trial: 14690568
Drug: Gemcitabine 1000
RxNorm normalized name: gemcitabine 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1000 mg/m2 + NS 100 ml or 200 ml (Group A)
Trial: 14690568
Drug: Gemcitabine 1000
RxNorm normalized name: gemcitabine 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1000 mg/m2 + Cisplatin 30 mg/m2 (Group B)
Trial: 14690568
Drug: Imported Gemzar
RxNorm normalized name: black imported fire ant allergenic extract
DrugBank: Solenopsis richteri (DB11026)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imported Gemzar + Cisplatin 30 mg/m2 (Group C)
Trial: 14690568
Drug: Cisplatin 30
RxNorm normalized name: Cisplatin
DrugBank: Cisplatin (DB00515)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cisplatin 30 mg/m2 (Group B)
Trial: 10768309
Drug: Topiramate (TPM)
RxNorm normalized name: Topiramate
DrugBank: Topiramate (DB00273)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Topiramate (TPM) at a mean dosage of 29 mg/kg/day, maximum dosage of 50 mg/kg/day, for a mean duration of 18 months.
Trial: 6376485
Drug: Isocarboxazid (40-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isocarboxazid (40-50 mg/day)
Trial: 28941006
Drug: 5 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 μg/kg palonosetron
Trial: 26795844
Drug: 10 μg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 μg/kg palonosetron
Trial: 24447683
Drug: α-glucosidase inhibitor
RxNorm normalized name: alpha glucosidase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α-glucosidase inhibitor (αGI)
Trial: 9113940
Drug: Salmeterol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol (50 microg once daily)
Trial: 3890504
Drug: Cimetidine, 300
RxNorm normalized name: Cimetidine, 300 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine, 300 mg orally every 6 hours
Trial: 30044959
Drug: Allogeneic umbilical
RxNorm normalized name: Allogeneic umbilical cord mesenchymal stem cells
DrugBank: Allogeneic umbilical cord mesenchymal stem cells (DB18367)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allogeneic umbilical cord-derived mesenchymal stem cells (MSCs) at doses of 1 × 10^6 cells/kg, 2 × 10^6 cells/kg, and 3 × 10^6 cells/kg
Trial: 22289995
Drug: High-dose dexamethasone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose dexamethasone (HD-DXM) 40 mg/day for 4 consecutive days
Trial: 20216531
Drug: Cognitive-behavioral treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral treatment targeting parents' responses and children's coping (3 sessions)
Trial: 12570912
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) replacement therapy at an initial dose of 0.125 IU/Kg/week followed by 0.250 IU/Kg/week
Trial: 12212211
Drug: Full-dose aprotinin
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Full-dose aprotinin (Group A, n = 10)
Trial: 1390529
Drug: Subconjunctival injection
RxNorm normalized name: STREPTOMYCES GRISEUS 0.05 g in 1 mL SUBCONJUNCTIVAL INJECTION, SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subconjunctival injection of cefuroxime (125 mg)
Trial: 1390529
Drug: Subconjunctival injection
RxNorm normalized name: STREPTOMYCES GRISEUS 0.05 g in 1 mL SUBCONJUNCTIVAL INJECTION, SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subconjunctival injection of both cefuroxime and Betnesol (betamethasone sodium phosphate 0.1%)
Trial: 4056964
Drug: Restrictive diets
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Restrictive diets based on oral food challenge results